STERIS CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2011-12-22: Form 8-K; Period of report 2011-12-20; Description 8.01 Other Events; Details 8.01.
- 2011-11-02: Form 8-K; Period of report 2011-11-02; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2011-08-02: Form 8-K; Period of report 2011-07-28; Description 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events; Details 2.02.
- 2011-05-09: Form 8-K; Period of report 2011-05-09; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2011-12-22 | 8-K | 2011-12-20 | 8.01 Other Events | 8.01 The U.S. Food and Drug Administration (“FDA”) extended by six months the period during which STERIS may provide support for SYSTEM 1®, including the ongoing sale of consumables (S20), as Customers complete their transition to an alternate processing technology. | d274643d8k.htm |
| 2011-11-02 | 8-K | 2011-11-02 | 2.02 Results of Operations and Financial Condition | 2.02 On November 2, 2011, STERIS issued a press release announcing financial results for its fiscal 2012 second quarter ended September 30, 2011. | d249749d8k.htm |
| 2011-08-02 | 8-K | 2011-07-28 | 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events | 2.02 On August 2, 2011, STERIS Corporation (“STERIS” or “Company”) issued a press release announcing financial results for its fiscal 2012 first quarter ended June 30, 2011. 5.02 As disclosed under Item 5.07, on July 28, 2011 the Company’s shareholders approved the amendment and restatement of the Company’s 2006 Long-Term Equity Incentive Plan, (the “Plan”). 5.07 At STERIS’s 2011 Annual Meeting of Shareholders (“Meeting”), held on July 28, 2011, shareholders voted on the following matters, with the final voting results as specified below. 8.01 As an update to the Company’s biological indicator submission, STERIS is continuing to seek FDA clearance of an optional, spore-based monitoring strip for use with the SYSTEM 1E® Liquid Chemical Sterilant Processing System. | d8k.htm |
| 2011-05-09 | 8-K | 2011-05-09 | 2.02 Results of Operations and Financial Condition | 2.02 On May 9, 2011, STERIS issued a press release announcing financial results for the three and twelve month periods ended March 31, 2011. | d8k.htm |
| 2011-03-21 | 8-K | 2011-03-18 | 8.01 Other Events | 8.01 The U.S. Food and Drug Administration (“FDA”) extended by six months the previously announced timeframe for U.S. healthcare providers to transition from SYSTEM 1® to an alternate processing technology. | d8k.htm |
| 2011-02-15 | 8-K | 2011-02-10 | 8.01 Other Events | 8.01 On February 10, 2011, STERIS Corporation received a warning letter from the U.S. Food and Drug Administration regarding our Verify® SixCess Class 6 Challenge Packs and Verify SixCess Class 6 Chemical Indicators. | d8k.htm |
| 2011-02-08 | 8-K | 2011-02-08 | 2.02 Results of Operations and Financial Condition | 2.02 On February 8, 2011, STERIS issued a press release announcing financial results for its fiscal 2011 third quarter ended December 31, 2010. | d8k.htm |